These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 12545702)

  • 21. The Advanced Glaucoma Intervention Study (AGIS): 13. Comparison of treatment outcomes within race: 10-year results.
    Ederer F; Gaasterland DA; Dally LG; Kim J; VanVeldhuisen PC; Blackwell B; Prum B; Shafranov G; Allen RC; Beck A;
    Ophthalmology; 2004 Apr; 111(4):651-64. PubMed ID: 15051195
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Deterioration of visual fields in patients with glaucoma with and without optic disc hemorrhages.
    Rasker MT; van den Enden A; Bakker D; Hoyng PF
    Arch Ophthalmol; 1997 Oct; 115(10):1257-62. PubMed ID: 9338670
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relationship between asymmetric central corneal thickness and glaucomatous visual field loss within the same patient.
    Sullivan-Mee M; Gentry JM; Qualls C
    Optom Vis Sci; 2006 Jul; 83(7):516-9. PubMed ID: 16840876
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pointwise linear regression for evaluation of visual field outcomes and comparison with the advanced glaucoma intervention study methods.
    Nouri-Mahdavi K; Caprioli J; Coleman AL; Hoffman D; Gaasterland D
    Arch Ophthalmol; 2005 Feb; 123(2):193-9. PubMed ID: 15710815
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Short-wavelength automated perimetry and motion automated perimetry in patients with glaucoma.
    Sample PA; Bosworth CF; Weinreb RN
    Arch Ophthalmol; 1997 Sep; 115(9):1129-33. PubMed ID: 9298053
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Early Manifest Glaucoma Trial: design and baseline data.
    Leske MC; Heijl A; Hyman L; Bengtsson B
    Ophthalmology; 1999 Nov; 106(11):2144-53. PubMed ID: 10571351
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term survival of central visual field in end-stage glaucoma.
    Much JW; Liu C; Piltz-Seymour JR
    Ophthalmology; 2008 Jul; 115(7):1162-6. PubMed ID: 18067965
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rate of progression in open-angle glaucoma estimated from cross-sectional prevalence of visual field damage.
    Quigley HA; Tielsch JM; Katz J; Sommer A
    Am J Ophthalmol; 1996 Sep; 122(3):355-63. PubMed ID: 8794708
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Short wavelength automated perimetry, frequency doubling technology perimetry, and pattern electroretinography for prediction of progressive glaucomatous standard visual field defects.
    Bayer AU; Erb C
    Ophthalmology; 2002 May; 109(5):1009-17. PubMed ID: 11986111
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical comparison of pascal dynamic contour tonometry and goldmann applanation tonometry in asymmetric open-angle glaucoma.
    Sullivan-Mee M; Halverson KD; Qualls C
    J Glaucoma; 2007 Dec; 16(8):694-9. PubMed ID: 18091457
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interocular asymmetry of visual field defects in primary open angle glaucoma and primary angle-closure glaucoma.
    Wang JC; Gazzard G; Foster PJ; Devereux JG; Oen FT; Chew PT; Khaw PT; Seah SK
    Eye (Lond); 2004 Apr; 18(4):365-8. PubMed ID: 15069431
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Visual field loss from primary angle-closure glaucoma: a comparative study of symptomatic and asymptomatic disease.
    Ang LP; Aung T; Chua WH; Yip LW; Chew PT
    Ophthalmology; 2004 Sep; 111(9):1636-40. PubMed ID: 15350315
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rate of visual field loss and long-term visual outcome in primary open-angle glaucoma.
    Kwon YH; Kim CS; Zimmerman MB; Alward WL; Hayreh SS
    Am J Ophthalmol; 2001 Jul; 132(1):47-56. PubMed ID: 11438053
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Perimetric progression using the Visual Field Index and the Advanced Glaucoma Intervention Study score and its clinical correlations.
    Gros-Otero J; Castejón M; Paz-Moreno J; Mikropoulos D; Teus M
    J Optom; 2015; 8(4):232-8. PubMed ID: 25182851
    [TBL] [Abstract][Full Text] [Related]  

  • 35. West Indies Glaucoma Laser Study (WIGLS)-2: Predictors of Selective Laser Trabeculoplasty Efficacy in Afro-Caribbeans With Glaucoma.
    Realini T; Shillingford-Ricketts H; Burt D; Balasubramani GK
    J Glaucoma; 2018 Oct; 27(10):845-848. PubMed ID: 29965865
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The development of a decision analytic model of changes in mean deviation in people with glaucoma: the COA model.
    Kymes SM; Lambert DL; Lee PP; Musch DC; Siegfried CJ; Kotak SV; Stwalley DL; Fain J; Johnson C; Gordon MO
    Ophthalmology; 2012 Jul; 119(7):1367-74. PubMed ID: 22537616
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence of open-angle glaucoma in Australia. The Blue Mountains Eye Study.
    Mitchell P; Smith W; Attebo K; Healey PR
    Ophthalmology; 1996 Oct; 103(10):1661-9. PubMed ID: 8874440
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Visual field progression in glaucoma: total versus pattern deviation analyses.
    Artes PH; Nicolela MT; LeBlanc RP; Chauhan BC
    Invest Ophthalmol Vis Sci; 2005 Dec; 46(12):4600-6. PubMed ID: 16303955
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Advanced Glaucoma Intervention Study (AGIS): 9. Comparison of glaucoma outcomes in black and white patients within treatment groups.
    AGIS Investigators
    Am J Ophthalmol; 2001 Sep; 132(3):311-20. PubMed ID: 11530042
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Progression from ocular hypertension to visual field loss in the English hospital eye service.
    Kelly SR; Khawaja AP; Bryan SR; Azuara-Blanco A; Sparrow JM; Crabb DP
    Br J Ophthalmol; 2020 Oct; 104(10):1406-1411. PubMed ID: 32217541
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.